Fredrik Jäderling

Publications
Grants
CV
Public outreach and news

Articles

Journal article: BMC UROLOGY. 2024;24(1):168

Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?

Jaderling F; Bergman M; Engel JC; Mortezavi A; Picker W; Haug ES; Eklund M; Nordstrom T
Article: JOURNAL OF MAGNETIC RESONANCE IMAGING. 2024;60(2):458-468

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Fernandez-Quilez A; Nordstrom T; Jaederling F; Kjosavik SR; Eklund M
Article: EUROPEAN RADIOLOGY. 2024;34(7):4801-4809

Manual prostate MRI segmentation by readers with different experience: a study of the learning progress

Langkilde F; Masaba P; Edenbrandt L; Gren M; Halil A; Hellstrom M; Larsson M; Naeem AA; Wallstrom J; Maier SE; Jaderling F
Journal article: LANCET ONCOLOGY. 2024;25(7):879-887

Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.

Saha A; Bosma JS; Twilt JJ; van Ginneken B; Bjartell A; Padhani AR; Bonekamp D; Villeirs G; Salomon G; Giannarini G; Kalpathy-Cramer J; Barentsz J; Maier-Hein KH; Rusu M; Rouvière O; van den Bergh R; Panebianco V; Kasivisvanathan V; Obuchowski NA; Yakar D; Elschot M; Veltman J; Fütterer JJ; de Rooij M; Huisman H; PI-CAI consortium
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e969

PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM

Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(4):e247131

Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial

Bjornebo L; Discacciati A; Falagario U; Vigneswaran HT; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Lantz A
Journal article: EUROPEAN UROLOGY. 2024;85:s1611

A0664 Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial

Discacciati A; Abbadi A; Chandra J; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Grönberg H; Eklund M; Nordström T
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2024;61:29-36

The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics-Real-world Evidence from 2018 to 2022

Palsdottir T; Soderback H; Jaderling F; Bergman M; Vigneswaran H; Gronberg H
Journal article: EUROPEAN UROLOGY. 2024;85:s459-s460

P331 Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram.

Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(2):e2354577

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial

Nordstrom T; Annerstedt M; Glaessgen A; Carlsson S; Clements M; Abbadi A; Groenberg H; Jaderling F; Eklund M; Discacciati A
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(4_suppl):295

The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI, and targeted biopsies: Real-world evidence from 2018 to 2022.

Palsdottir T; Söderbäck H; Jäderling F; Bergman M; Vigneswaran HT; Gronberg H
Journal article: ANNALS OF ONCOLOGY. 2023;34:s1577

The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI and targeted biopsies: Real-world evidence from 2018 to 2022

Vigneswaran H; Soderback H; Jaderling F; Bergman M; Gronberg H; Palsdottir T
Article: LAKARTIDNINGEN. 2023;120:23077

[Improved prostate cancer diagnostics with a structured pathway including »Stockholm 3« test, MRI and targeted perineal biopsies].

Söderbäck H; Jäderling F; Wimmerkranz F; Andersson J; Bergman M; Nordström T; Grönberg H
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;51:89-94

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

Lantz A; Nordlund P; Falagario U; Joderling F; Ozbek O; Clements M; Discacciati A; Gronberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordstrom T
Journal article: EUROPEAN UROLOGY. 2023;83:s1268

Repeat prostate cancer screening using prostate-specific antigen, a multiplex bloodtest and magnetic resonance imaging: 2nd screening round outcomes of STHLM3-MRI

Nordstrom T; Discacciati A; Annerstedt M; Mannsikka K; Glaessgen A; Carlsson S; Jaderling F; Gronberg H; Eklund M
Article: BMJ HEALTH & CARE INFORMATICS. 2022;29(1):e100588

Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care

Ronmark E; Hoffmann R; Skokic V; de Klerk-Starmans M; Jaderling F; Vos P; Gayet MCW; Hofstraat H; Janssen M; Akre O; Vincent PH
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:63-73

Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer

Gongora M; Stranne J; Johansson E; Bottai M; Karlsson CT; Brasso K; Hansen S; Jakobsen H; Jaderling F; Lindberg H; Lilleby W; Petersen PM; Mirtti T; Olsson M; Rannikko A; Roder MA; Vincent PH; Akre O
Article: EUROPEAN UROLOGY. 2022;82(1):12-19

Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2021;58(5):773-779

Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer

Palsdottir K; Fridsten S; Blomqvist L; Alagic Z; Fischerova D; Gaurilcikas A; Hasselrot K; Jaderling F; Testa AC; Sundin A; Epstein E
Article: MAGNETIC RESONANCE IN MEDICINE. 2021;86(4):2025-2033

Mapping prostatic microscopic anisotropy using linear and spherical b-tensor encoding: A preliminary study

Nilsson M; Eklund G; Szczepankiewicz F; Skorpil M; Bryskhe K; Westin C-F; Lindh C; Blomqvist L; Jaderling F
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(10):908-920

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Groenberg H; Nordstroem T
Article: LANCET ONCOLOGY. 2021;22(9):1240-1249

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Nordstrom T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Article: WORLD JOURNAL OF UROLOGY. 2021;39(6):1797-1804

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer

Bjornebo L; Olsson H; Nordstrom T; Jaderling F; Gronberg H; Eklund M; Lantz A
Journal article: EUROPEAN UROLOGY. 2021;79:s1429

P1014 Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial

Nordström T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Journal article: EUROPEAN UROLOGY. 2021;79:s1430

P1015 MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial

Eklund M; Jäderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Grönberg H; Nordström T
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(5):632-640

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Olsson H; Nordstrom T; Jaderling F; Egevad L; Vigneswaran HT; Annerstedt M; Gronberg H; Eklund M; Lantz A
Article: WORLD JOURNAL OF UROLOGY. 2021;39(4):1153-1159

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Lantz A; Haug ES; Picker W; Crippa A; Jaderling F; Mortezavi A; Nordstrom T
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(4):318-322

The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS trial

Carlsson S; Bratt O; Kristiansson D; Jaderling F
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e182

58 Adding random systematic biopsies to MRI-fusion targeted prostate biopsy procedures: Always, in selected cases, or never?

Bergman MCA; Mortezawi A; Picker W; Aly M; Jäderling F; Haug E; Eklund M; Nordström T
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps378

MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI.

Nordström T; Discacciati A; Jäderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps379

Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).

Lantz A; Olsson H; Nordström T; Jäderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496

A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging

Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(3):391-398

Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery

Jaderling F; Akre O; Aly M; Bjorklund J; Olsson M; Adding C; Oberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S
Article: BMJ OPEN. 2019;9(8):e027860

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Ahlberg MS; Adami H-O; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jaderling F; Wassberg C; Aberg UWN; Bill-Axelson A
Article: BMJ OPEN. 2019;9(6):e027816

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
Article: ONCOLOGIST. 2019;24(6):745-e213

Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

Shah C-H; Pappot H; Agerbaek M; Holmsten K; Jaderling F; Yachnin J; Gryback P; von der Maase H; Ullen A
Article: EUROPEAN UROLOGY. 2018;74(6):722-728

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2018;52(5-6):313-320

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer

Stranne J; Brasso K; Brennhovd B; Johansson E; Jaderling F; Kouri M; Lilleby W; Petersen PM; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(14):e3001

P162 Safety and activity of sorafenib in addition to vinflunine in post-platinum metastatic urothelial carcinoma (Vinsor): Phase I trial

Shah C-H; Pappot H; Agerbæk M; Holmsten K; Jäderling F; Yachnin J; Grybäck P; Von Der Maase H; Ullén A
Article: LAKARTIDNINGEN. 2018;115:FCDT

[Improved prostate cancer diagnostics with a struc-tured pathway including the Stockholm3 test and MRI--targeted biopsies - experiences from Capio S:t Göran Prostate Cancer Center].

Bergman M; Hjälm Ericsson M; Jäderling F; Meurling E; Thorstensson A; Nordström T; Henrik G
Article: ACTA RADIOLOGICA OPEN. 2018;7(2):2058460118754607-205846011875460

Accuracy in local staging of prostate cancer by adding a three-dimensional T2-weighted sequence with radial reconstructions in magnetic resonance imaging

Jaderling F; Nyberg T; Oberg M; Carlsson S; Skorpil M; Blomqvist L
Article: PLOS ONE. 2018;13(6):e0199477

Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study

Ebbing J; Jaderling F; Collins JW; Akre O; Carlsson S; Hoijer J; Olsson MJ; Wiklund PN
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(10):e2628-e2629

O2 A multistep approach for detection of prostate cancer using prostate-specific antigen, the Stockholm 3 Test, and MRI-targeted Biopsies: Initial data from the STHLM3 MRI Project

Nordström; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(6):e2279-e2280

PE24 Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study

Ebbing J; Jäderling F; Collins JW; Akre O; Carlsson S; Höijer J; Olsson MJ; Wiklund PN
Article: BJU INTERNATIONAL. 2017;119(2):289-297

Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma

Grahn A; Melle-Hannah M; Malm C; Jaderling F; Radecka E; Beckman M; Brehmer M
Article: ONCOLOGY LETTERS. 2016;12(2):1293-1300

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Holmsten K; Dohn LH; Jensen NV; Shah C-H; Jaderling F; Pappot H; Ullen A
Article: BJU INTERNATIONAL. 2016;118(2):205-212

Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial

Carlsson S; Jaderling F; Wallerstedt A; Nyberg T; Stranne J; Thorsteinsdottir T; Carlsson SV; Bjartell A; Hugosson J; Haglind E; Steineck G
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(4):260-266

Accurate prediction tools in prostate cancer require consistent assessment of included variables

Jaderling F; Nyberg T; Blomqvist L; Bjartell A; Steineck G; Carlsson S
Article: LAKARTIDNINGEN. 2015;112:DFZ3

[Go for MRI in the diagnosis of prostate cancer].

Bratt O; Ahlgren G; Andrén O; Blomqvist L; Carlsson S; Damber JE; Hugosson J; Jäderling F; Karlsson CT; Robinson D
Article: EUROPEAN RADIOLOGY. 2010;20(3):630-639

Evaluation of image quality and lesion perception by human readers on 3D CT colonography: comparison of standard and low radiation dose

Fisichella VA; Bath M; Johnsson AA; Jaderling F; Bergsten T; Persson U; Mellingen K; Hellstrom M
Article: CLINICAL RADIOLOGY. 2009;64(10):972-982

Computer-aided detection (CAD) as a second reader using perspective filet view at CT colonography: effect on performance of inexperienced readers

Fisichella VA; Jaderling F; Horvath S; Stotzer P-O; Kilander A; Bath M; Hellstrom M
Article: ACTA RADIOLOGICA. 2009;50(3):244-255

Primary Three-Dimensional Analysis with Perspective-Filet View Versus Primary Two-Dimensional Analysis: Evaluation of Lesion Detection by Inexperienced Readers at Computed Tomographic Colonography in Symptomatic Patients

Fisichella VA; Jaderling F; Horvath S; Stotzer P-O; Kilander A; Hellstrom M
Journal article: OPPORTUNISTIC PATHOGENS. 1993;5(4):209-216

Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus

Silvestri M; Jäderling F; Rudén U; Ohlin M; Sundqvist V-A
Show more

All other publications

Corrigendum: EUROPEAN UROLOGY. 2022;82(1):e21

Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study (vol 82, pg 12, 2022)

Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
Editorial comment: JOURNAL OF UROLOGY. 2022;207(1):231

Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: MEDRXIV. 2021

Cost-effectiveness of Stockholm3 test and magnetic resonance imaging in prostate cancer screening: a microsimulation study

Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements M
Conference publication: EUROPEAN UROLOGY. 2021;79:S1429

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial

Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1430

MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial

Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: SSRN ELECTRONIC JOURNAL. 2021

Prostate Cancer Screening Using a Combination of Risk-Prediction, Magnetic Resonance Imaging and Targeted Prostate Biopsies: A Randomised Trial

Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)

Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS)

Lantz A; Olsson H; Nordstrom T; Jaderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)

MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI

Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2019;53:40

Improved prostate cancer diagnostics with a structured pathway including the Stockholm3 test and MRI-targeted biopsies led by nurses

Thorstenson A; Melander-Bergstrom C; Cavalli-Bjorkman C; Bergman M; Hjelm-Eriksson M; Jaderling F; Meurling E; Nordstrom T; Gronberg H
Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528

Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project

Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Corrigendum: ONCOLOGY LETTERS. 2017;13(6):5035

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis (vol 12, pg 1293, 2016)

Holmsten K; Dohn L; Jensen NV; Shah C-H; Jaderling F; Pappot H; Ullen A
Thesis / dissertation: 2016

Preoperative local staging of prostate cancer : aspects on predictive models, magnetic resonance imaging and interdisciplinary teamwork

Jäderling, Fredrik
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2013;47:30-31

Diagnostic accuracy of ct and ureteroscopy in urothelial carcinoma of the upper urinary tract

Grahn A; Melle-Hannah M; Malm C; Jaderling F; Radecka EE; Beckman M; Brehmer M

Grants

Artificial intelligence for reproducible MRI diagnosis of prostate cancer

Swedish Research Council

1 January 2021 - 31 December 2023
SPCG-15: SURGERY VERSUS RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: A RANDOMIZED CLINICAL TRIAL.

Swedish Research Council

1 December 2017 - 31 December 2018

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2017
University Medical Degree, Karolinska Institutet, 1997

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI